{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:16:14Z","timestamp":1794975374676,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350125, 82173763"],"award-info":[{"award-number":["82350125, 82173763"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-00950-1","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:03:29Z","timestamp":1745903009000},"page":"838-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-2846","authenticated-orcid":false,"given":"Weiqiang","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongdeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuolin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benkang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0074-6876","authenticated-orcid":false,"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"950_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","volume":"614","author":"L Labanieh","year":"2023","unstructured":"Labanieh, L. & Mackall, C. L. CAR immune cells: design principles, resistance and the next generation. Nature 614, 635\u2013648 (2023).","journal-title":"Nature"},{"key":"950_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.abq6990","volume":"378","author":"DJ Irvine","year":"2022","unstructured":"Irvine, D. J., Maus, M. V., Mooney, D. J. & Wong, W. W. The future of engineered immune cell therapies. Science 378, 853\u2013858 (2022).","journal-title":"Science"},{"key":"950_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"950_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947\u2013953 (2020).","journal-title":"Nat. Biotechnol."},{"key":"950_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"950_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia, Y. et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv. Mater. 32, e2002054 (2020).","journal-title":"Adv. Mater."},{"key":"950_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","volume":"169","author":"S Chevrier","year":"2017","unstructured":"Chevrier, S. et al. An immune atlas of clear cell renal cell carcinoma. Cell 169, 736\u2013749.e718 (2017).","journal-title":"Cell"},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(22)01059-5","volume":"400","author":"GD Stewart","year":"2022","unstructured":"Stewart, G. D. et al. The multispeciality approach to the management of localised kidney cancer. Lancet 400, 523\u2013534 (2022).","journal-title":"Lancet"},{"key":"950_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier, B. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann. Oncol. 30, 706\u2013720 (2019).","journal-title":"Ann. Oncol"},{"key":"950_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","volume":"39","author":"DA Braun","year":"2021","unstructured":"Braun, D. A. et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 39, 632\u2013648 e638 (2021).","journal-title":"Cancer Cell"},{"key":"950_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"950_CR12","doi-asserted-by":"publisher","first-page":"e006195","DOI":"10.1136\/jitc-2022-006195","volume":"11","author":"NH Chakiryan","year":"2023","unstructured":"Chakiryan, N. H. et al. Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. J. Immunother. Cancer 11, e006195 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"950_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-med-073118-011031","volume":"72","author":"WW Overwijk","year":"2021","unstructured":"Overwijk, W. W., Tagliaferri, M. A. & Zalevsky, J. Engineering IL-2 to give new life to T cell immunotherapy. Annu. Rev. Med. 72, 281\u2013311 (2021).","journal-title":"Annu. Rev. Med."},{"key":"950_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41581-020-0316-3","volume":"16","author":"CM Diaz-Montero","year":"2020","unstructured":"Diaz-Montero, C. M., Rini, B. I. & Finke, J. H. The immunology of renal cell carcinoma. Nat. Rev. Nephrol. 16, 721\u2013735 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.eururo.2005.03.031","volume":"48","author":"N Verra","year":"2005","unstructured":"Verra, N. et al. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy. Eur. Urol. 48, 527\u2013533 (2005).","journal-title":"Eur. Urol."},{"key":"950_CR16","doi-asserted-by":"publisher","first-page":"26895","DOI":"10.1073\/pnas.2011667117","volume":"117","author":"L Swanson","year":"2020","unstructured":"Swanson, L. et al. TLR4 signaling and macrophage inflammatory responses are dampened by GIV\/Girdin. Proc. Natl Acad. Sci. USA 117, 26895\u201326906 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"950_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi, G. & Karin, M. The two NF-\u03baB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280\u2013288 (2004).","journal-title":"Trends Immunol."},{"key":"950_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat. Rev. Immunol. 18, 648\u2013659 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"950_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100123","volume":"4","author":"D Peerlings","year":"2021","unstructured":"Peerlings, D., Mimpen, M. & Damoiseaux, J. The IL-2 - IL-2 receptor pathway: key to understanding multiple sclerosis. J. Transl. Autoimmun. 4, 100123 (2021).","journal-title":"J. Transl. Autoimmun."},{"key":"950_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej, K. M. et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol. Cancer 22, 20 (2023).","journal-title":"Mol. Cancer"},{"key":"950_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1128","volume":"14","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Intracavity generation of glioma stem cell-specific CAR macrophages pr imes locoregional immunity for postoperative glioblastoma therapy. Sci. Transl. Med. 14, eabn1128 (2022).","journal-title":"Sci. Transl. Med."},{"key":"950_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.semcancer.2022.01.001","volume":"86","author":"A Queen","year":"2022","unstructured":"Queen, A., Bhutto, H. N., Yousuf, M., Syed, M. A. & Hassan, M. I. Carbonic anhydrase IX: a tumor acidification switch in heterogeneity and chemokine regulation. Semin. Cancer Biol. 86, 899\u2013913 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","volume":"31","author":"J Pastorek","year":"2015","unstructured":"Pastorek, J. & Pastorekova, S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. Semin. Cancer Biol. 31, 52\u201364 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"950_CR24","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.7150\/thno.21848","volume":"7","author":"J Lau","year":"2017","unstructured":"Lau, J., Lin, K. S. & Benard, F. Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX. Theranostics 7, 4322\u20134339 (2017).","journal-title":"Theranostics"},{"key":"950_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-022-04801-2","volume":"607","author":"A Kalbasi","year":"2022","unstructured":"Kalbasi, A. et al. Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature 607, 360\u2013365 (2022).","journal-title":"Nature"},{"key":"950_CR26","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1016\/j.cell.2022.11.029","volume":"185","author":"S Morioka","year":"2022","unstructured":"Morioka, S. et al. Chimeric efferocytic receptors improve apoptotic cell clearance and alleviate inflammation. Cell 185, 4887\u20134903 e4817 (2022).","journal-title":"Cell"},{"key":"950_CR27","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"C-X Liu","year":"2022","unstructured":"Liu, C.-X. & Chen, L.-L. Circular RNAs: characterization, cellular roles, and applications. Cell 185, 2016\u20132034 (2022).","journal-title":"Cell"},{"key":"950_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728\u20131744.e1716 (2022).","journal-title":"Cell"},{"key":"950_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262\u2013272 (2023).","journal-title":"Nat. Biotechnol."},{"key":"950_CR30","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"950_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"key":"950_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","volume":"17","author":"G Guerrini","year":"2022","unstructured":"Guerrini, G., Magri, D., Gioria, S., Medaglini, D. & Calzolai, L. Characterization of nanoparticles-based vaccines for COVID-19. Nat. Nanotechnol. 17, 570\u2013576 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"950_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11911-5","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat. Commun. 10, 3974 (2019).","journal-title":"Nat. Commun."},{"key":"950_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","volume":"343","author":"JE Zhou","year":"2022","unstructured":"Zhou, J. E. et al. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J. Control. Release 343, 175\u2013186 (2022).","journal-title":"J. Control. Release"},{"key":"950_CR35","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1016\/j.cell.2021.07.009","volume":"184","author":"SW Choi","year":"2021","unstructured":"Choi, S. W., Guan, W. & Chung, K. Basic principles of hydrogel-based tissue transformation technologies and their applications. Cell 184, 4115\u20134136 (2021).","journal-title":"Cell"},{"key":"950_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.urology.2006.08.1073","volume":"68","author":"O Shvarts","year":"2006","unstructured":"Shvarts, O. et al. RENCA\/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma. Urology 68, 1132\u20131138 (2006).","journal-title":"Urology"},{"key":"950_CR37","doi-asserted-by":"publisher","unstructured":"Thomas, T. T. et al. Utilization of ultrasound guided tissue-directed cellular implantation for the establishment of biologically relevant metastatic tumor xenografts. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57558 (2018).","DOI":"10.3791\/57558"},{"key":"950_CR38","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon, B. G. et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity 55, 2044\u20132058 e2045 (2022).","journal-title":"Immunity"},{"key":"950_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten, K. et al. Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer. Cancer Cell 40, 624\u2013638 e629 (2022).","journal-title":"Cancer Cell"},{"key":"950_CR40","doi-asserted-by":"publisher","first-page":"e002628","DOI":"10.1136\/jitc-2021-002628","volume":"9","author":"J Guo","year":"2021","unstructured":"Guo, J., Kent, A. & Davila, E. Chimeric non-antigen receptors in T cell-based cancer therapy. J. Immunother. Cancer 9, e002628 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"950_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu, D., Wu, Y. & Lian, J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct. Target Ther. 8, 341 (2023).","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00950-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:07:09Z","timestamp":1748506029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00950-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-00950-1","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}